PRA023 IMPROVED HEALTH-RELATED QUALITY OF LIFE AS MEASURED BY IBDQ-32 IN A PHASE 2 TRIAL FROM PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Laurent Peyrin-Biroulet  1     Bruce E. Sands  2     Silvio Danese  3     David T. Rubin  4     Deanna Nguyen  5     Quinn Dinh  5     Alina Melnyk  5     Bin Dong  5     Christopher Ma  6     Timothy Ritter  7     Remo Panaccione  8    
1 Last Inserm U954 and CHU de Nancy, Lorraine University, Nancy, France
2 Icahn School of Medicine at Mount Sinai, New York, United States
3 Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milano, Italy
4 University of Chicago Medicine, Chicago, United States
5 Prometheus Biosciences, Inc., San Diego, United States
6 University of Calgary, Departments of Medicine and Community Health Sciences, Calgary, Canada
7 GI Alliance, Southlake, United States
8 University of Calgary, Calgary, Canada

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing